MedTrace Logo

The Impact of a Predictive Hypoglycaemia Alert Function in Physical Activity for People With T1DM

NCT04142944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-11-12

No results posted yet for this study

Summary

Observational, within-subject, crossover study

To assess the impact of Dexcom G6 RT-CGM with a predictive hypoglycaemia alert function on the frequency, duration and severity of hypoglycaemia occurring before, during and after regular physical activity in people with type 1 diabetes

At Imperial College Healthcare NHS Trust have established the multi-disciplinary Imperial Physical Activity and Diabetes (IPAD) clinic to empower, educate and enable people with diabetes to manage their blood glucose when they undertake physical activity. The investigator utilise the skills and expertise of a consultant diabetologist, a diabetes dietitian, a consultant in sports \& exercise medicine, and a diabetes specialist nurse with expertise in diabetes technology. The investigator have access to diagnostic \& therapeutic radiology, physiotherapy and psychology services.

Conditions

  • Type1diabetes

Interventions

DEVICE

Dexcom G6 with alert

Dexcom G6 CGM device with the predictive hypoglycaemia alert function

DEVICE

Dexcom G6 without alert

Dexcom G6 CGM device without the predictive hypoglycaemia alert function

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Neil Hill · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-11
Primary Completion
2021-07-27
Completion
2021-07-27
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04142944 on ClinicalTrials.gov